Vanda Pharmaceuticals
Price & Volume
Stats
See moreOpen | $5.03 |
Previous Close | $5 |
Day Range | $4.98-$5.17 |
52W Range | $3.80-$5.70 |
Market Cap | $295.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $212M |
Revenue Growth (YoY) | 18.1% |
Gross Profit (12 Mos) | $200.2M |
Diluted EPS | -$1.44 |
News
See moreYahoo Finance • 8 days ago
Vanda Pharmaceuticals Surges 21% After Positive Tradipitant Trial In GLP-1 Adjunct Setting
Yahoo Finance • 8 days ago
Vanda's tradipitant can significantly reduce nausea in those taking a GLP-1
Yahoo Finance • 29 days ago
Jim Cramer on Vanda Pharmaceuticals: “I’m Going to Bless That One as Your Spec”
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 368 |
